Compare AANJANEYA LIFECARE with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS TTK HEALTHCARE DR. DATSONS LABS/
TTK HEALTHCARE
 
P/E (TTM) x -10.9 18.4 - View Chart
P/BV x 0.2 1.5 11.0% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 DR. DATSONS LABS   TTK HEALTHCARE
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
TTK HEALTHCARE
Mar-19
DR. DATSONS LABS/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1261,215 10.3%   
Low Rs31610 5.1%   
Sales per share (Unadj.) Rs133.0444.4 29.9%  
Earnings per share (Unadj.) Rs0.217.2 0.9%  
Cash flow per share (Unadj.) Rs6.627.6 23.9%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs128.8177.9 72.4%  
Shares outstanding (eoy) m31.6614.13 224.1%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.1 28.7%   
Avg P/E ratio x516.152.9 975.5%  
P/CF ratio (eoy) x11.833.0 35.9%  
Price / Book Value ratio x0.65.1 11.8%  
Dividend payout %029.0 0.0%   
Avg Mkt Cap Rs m2,47712,894 19.2%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m561,307 4.3%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m4,2116,279 67.1%  
Other income Rs m7978 101.5%   
Total revenues Rs m4,2896,356 67.5%   
Gross profit Rs m569496 114.7%  
Depreciation Rs m204147 139.3%   
Interest Rs m43034 1,272.8%   
Profit before tax Rs m13393 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6149 4.1%   
Profit after tax Rs m5244 2.0%  
Gross profit margin %13.57.9 171.1%  
Effective tax rate %48.037.9 126.6%   
Net profit margin %0.13.9 2.9%  
BALANCE SHEET DATA
Current assets Rs m6,8522,717 252.2%   
Current liabilities Rs m6,7111,571 427.2%   
Net working cap to sales %3.318.3 18.3%  
Current ratio x1.01.7 59.0%  
Inventory Days Days16132 500.2%  
Debtors Days Days31847 682.7%  
Net fixed assets Rs m3,673991 370.6%   
Share capital Rs m317141 224.1%   
"Free" reserves Rs m3,7612,373 158.5%   
Net worth Rs m4,0782,514 162.2%   
Long term debt Rs m1,6713 49,141.2%   
Total assets Rs m12,6334,158 303.8%  
Interest coverage x1.012.6 8.2%   
Debt to equity ratio x0.40 30,301.8%  
Sales to assets ratio x0.31.5 22.1%   
Return on assets %3.46.7 51.6%  
Return on equity %0.19.7 1.2%  
Return on capital %7.716.9 45.3%  
Exports to sales %22.93.6 638.3%   
Imports to sales %14.30.5 2,900.1%   
Exports (fob) Rs m964225 428.1%   
Imports (cif) Rs m60231 1,944.7%   
Fx inflow Rs m964225 428.1%   
Fx outflow Rs m60771 853.7%   
Net fx Rs m357154 231.6%   
CASH FLOW
From Operations Rs m1,345173 776.9%  
From Investments Rs m-2,25697 -2,337.4%  
From Financial Activity Rs m-1,200-307 390.4%  
Net Cashflow Rs m-2,111-38 5,598.7%  

Share Holding

Indian Promoters % 4.5 65.4 6.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 1.4 5.2 26.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 25.8 364.7%  
Shareholders   20,807 12,723 163.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PFIZER  FDC LTD.  SUN PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS